Fig. 2From: Is early use of sodium-glucose cotransporter type 2 inhibitor (SGLT2i) necessary even in diabetic patients without cardiovascular disease: a prospective study regarding the effect of SGLT2i on left ventricular diastolic functionChanges of E/e’ according to the presence of cardiovascular risk factorsBack to article page
